Forte Biosciences
Stock Forecast, Prediction & Price Target
Forte Biosciences Financial Estimates
Forte Biosciences Revenue Estimates
Forte Biosciences EBITDA Estimates
Forte Biosciences Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $9M Low: $9M High: $9M avg. 0% | Avg: $22.5M Low: $22.5M High: $22.5M avg. 150% | Avg: $31.49M Low: $31.49M High: $31.49M avg. 39.95% |
Net Income
% change YoY
| $-21.70M N/A | $-13.86M 36.14% | $-31.47M -127.06% | Avg: $-16.41M Low: $-20.29M High: $-12.83M avg. 47.84% | Avg: $-17.67M Low: $-17.67M High: $-17.67M avg. -7.69% | Avg: $-15.94M Low: $-15.94M High: $-15.94M avg. 9.82% | Avg: $-14.20M Low: $-14.20M High: $-14.20M avg. 10.89% |
EBITDA
% change YoY
| $-21.45M N/A | $-13.89M 35.21% | $-32.47M -133.71% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.55 N/A | -$0.8 48.38% | -$24.92 -3015% | Avg: -$0.52 Low: -$0.64 High: -$0.41 avg. 97.91% | Avg: -$0.56 Low: -$0.56 High: -$0.56 avg. -7.69% | Avg: -$0.51 Low: -$0.51 High: -$0.51 avg. 9.82% | Avg: -$0.45 Low: -$0.45 High: -$0.45 avg. 10.89% |
Operating Expenses
% change YoY
| $21.48M N/A | $13.89M -35.32% | $32.47M 133.71% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Forte Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 15.21% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -20.29M, average is -16.41M and high is -12.83M.
What is Forte Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 47.48% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Forte Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 27.73% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.64, average is -$0.52 and high is $-0.40.